Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

dc.contributor.author	DURSUN, O
dc.contributor.author	GEDIK, H
dc.contributor.author	ERKEK, N
dc.contributor.author	KOROGLU, TF
dc.contributor.author	KARABÖCÜOĞLU, Metin
dc.contributor.author	CARCILLO, JA
dc.contributor.author	Turkish, Secondary
dc.contributor.author	YILDIZDAS, D
dc.contributor.author	BAYRAKCI, B
dc.contributor.author	KARAPINAR, B
dc.contributor.author	KENDIRLI, T
dc.contributor.author	Demirkol, Demet
dc.contributor.author	CITAK, Agop
dc.contributor.author	KESICI, S
dc.date.accessioned	2021-03-05T22:04:16Z
dc.date.available	2021-03-05T22:04:16Z
dc.identifier.citation	Demirkol D., YILDIZDAS D., BAYRAKCI B., KARAPINAR B., KENDIRLI T., KOROGLU T., DURSUN O., ERKEK N., GEDIK H., CITAK A., et al., "Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?", Critical care (London, England), cilt.16, 2012
dc.identifier.other	av_dbe6f3d4-1514-4f2c-b9df-fdeb403414ef
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/144946
dc.identifier.uri	https://doi.org/10.1186/cc11256
dc.language.iso	eng
dc.title	Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
dc.type	Makale
dc.relation.journal	Critical care (London, England)
dc.contributor.department	, ,
dc.identifier.volume	16
dc.contributor.firstauthorID	186046

Bu öğenin dosyaları:

Dosyalar	Boyut	Biçim	Göster
Bu öğe ile ilişkili dosya yok.